<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>halichondrinb </title>
</head>
<link href="https://fonts.googleapis.com/css2?family=Baloo+Bhai+2:wght@600&display=swap" rel="stylesheet">
<link rel="stylesheet" href="style.css">
<style>
    body {
        font-family: 'Baloo Bhai 2', cursive;
        margin-left: 60px;
        padding: 0;


    }

    .plant {
        width: 80%;
        font-size: 34px;
        /* margin-left: 60px; */
    }

    .intro {

        width: 80%;
        /* margin-left: 60px; */
        margin-top: 18px;
        font-size: 21px;
    }

    .org {
        font-size: 25px;
        margin-left: -18px;
    }
</style>

<body>
    <div class="plant"><u>Halichondrin B</u> :</div>
    <div class="intro">Halichondrin B is a polyether macrolide originally isolated from the marine sponge Halichondria
        okadai by Hirata and Uemura in 1986.[1] In the same report, these authors also reported the exquisite anticancer
        activity of halichondrin B against murine cancer cells both in culture and in in vivo studies. </div>

    <ul type="disc">
        <li class="org">Origin </li>
        <div class="intro">Halichondria okadai,
            Lissodendoryx sp.,
            Phakellia carteri,
            Axinella sp.</div>
        <li class="org">Structure-Activity Relationship (SAR) </li>
        <div class="intro">Analysis of the halichondrin SAR revealed that significant structural variations of the C-30
            to C-54 side chain have only minimal effects on potency. Eisai has subsequently developed substantially
            simplified analogs, ER-086526 10 and ER-076349 11, that demonstrate subnanomolar IC50 values versus a
            variety of human cancer cell lines.52â€“54 ER-086526 (E7389) is currently undergoing phase I human clinical
            trials.

        </div>
        <img class="img" src="Halichondrin B.jpg" alt=" helichondrin sar fig">
        <li class="org">Mechanism Of Action</li>
        <div class="intro">mechanism of action (in this case, tubulin-targeted mitotic inhibitor) by NCI's
            then-brand-new "60-cell line screen</div>
        
        <li class="org">Target cells</li>
        <div class="intro">L1210 murine leukaemia cells</div>
    </ul>
</body>

</html>